Clearance Summary
BD Preset Syringe & BD A-Line Syringe received FDA 510(k) clearance under submission number K202446, sponsored by Becton, Dickinson and Company. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2020-09-25.
- Submission: K202446
- Applicant / Sponsor: Becton, Dickinson and Company
- Clearance pathway: Special
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1675
- Decision date: 2020-09-25
Classification & Regulation
This clearance is catalogued under FDA product code JKA and 21 CFR 862.1675, within the Clinical Chemistry review panel as a Class II device.